Compare Tata Chemicals with Similar Stocks
Stock DNA
Commodity Chemicals
INR 18,043 Cr (Small Cap)
57.00
13
1.56%
0.28
1.65%
0.80
Total Returns (Price + Dividend) 
Latest dividend: 11 per share ex-dividend date: Jun-12-2025
Risk Adjusted Returns v/s 
Returns Beta
News
Are Tata Chemicals Ltd. latest results good or bad?
Tata Chemicals Ltd. has reported its financial results for the third quarter of FY26, revealing significant operational challenges. The company experienced a net loss of ₹39 crores, contrasting sharply with a profit of ₹77 crores in the previous quarter. This loss highlights a substantial decline in profitability, driven by a notable contraction in operating margins, which fell to 13.85% from 17.45% in the prior quarter. While revenue showed a sequential growth of 4.25% to ₹3,877 crores, this modest increase was overshadowed by a 17.26% decline in operating profit before depreciation, interest, tax, and other income (PBDIT), which dropped to ₹537 crores. Year-on-year comparisons also indicate a decline in net sales by 3.05% compared to the same quarter last year, alongside a significant reduction in operating profit, which decreased by 13.11%. The company's return on equity (ROE) stands at a weak 5.64%, s...
Read full news article
Tata Chemicals Q3 FY26: Profit Plunge Deepens as Margin Pressures Mount
Tata Chemicals Limited has reported a consolidated net loss of ₹39.00 crores for Q3 FY26, marking a dramatic reversal from the ₹77.00 crore profit recorded in Q2 FY26. The commodity chemicals major, with a market capitalisation of ₹18,430 crores, witnessed its stock decline 2.27% to ₹726.15 following the results announcement, extending a troubling pattern of underperformance that has seen the stock shed 24.71% over the past year. The quarter's results underscore mounting operational challenges, with operating margins contracting sharply despite modest revenue growth, raising serious questions about the sustainability of earnings in the current demand environment.
Read full news article
Tata Chemicals Ltd. is Rated Sell
Tata Chemicals Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 January 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news article Announcements 
Tata Chemicals Limited - Other General Purpose
13-Nov-2019 | Source : NSETata Chemicals Limited has informed the Exchange regarding Disclosure of Related Party Transactions for the half year ended September 30, 2019 pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Tata Chemicals Limited - Analysts/Institutional Investor Meet/Con. Call Updates
06-Nov-2019 | Source : NSETata Chemicals Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates
Tata Chemicals Limited - Press Release
31-Oct-2019 | Source : NSETata Chemicals Limited has informed the Exchange regarding a press release dated October 30, 2019, titled "Press Release on the Financial Results for the second quarter and half year ended September 30, 2019".
Corporate Actions 
No Upcoming Board Meetings
Tata Chemicals Ltd. has declared 110% dividend, ex-date: 12 Jun 25
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 34 Schemes (9.94%)
Held by 162 FIIs (12.26%)
Tata Sons Private Limited (31.9%)
Life Insurance Corporation Of India - P & Gs Fund (9.24%)
23.4%
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is -8.43% vs 4.25% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is -220.78% vs -69.44% in Sep 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is -2.47% vs -5.21% in Sep 2024
Growth in half year ended Sep 2025 is -4.36% vs -64.17% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is -2.04% vs -4.75% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -18.90% vs -73.97% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is -3.46% vs -8.15% in Mar 2024
YoY Growth in year ended Mar 2025 is -12.31% vs -88.43% in Mar 2024






